ロード中...
Efficacy and safety of tiotropium Respimat(®) SMI in COPD in two 1-year randomized studies
Two 1-year studies evaluated the long-term efficacy and safety of tiotropium 5 or 10 μg versus placebo, inhaled via the Respimat(®) Soft Mist™ Inhaler (SMI). The two studies were combined and had 4 co-primary endpoints (trough FEV(1) response, Mahler Transition Dyspnea Index [TDI] and St George’s Re...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2921687/ https://ncbi.nlm.nih.gov/pubmed/20714373 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|